Logos are each company's own site icon, matched by name through Wikidata.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.
FDA establishment 1000125727, Coeur d Alene, Idaho, United States. Part of 21st Century Scientific, Inc.'s FDA records. Every inspection FDA has posted for the site, with its outcome and cited regulations.
Inspections: 5
Official action indicated: 1
Last inspection ended: Sep 17, 2021
Warning letters: 2
Inspections by Fiscal Year
FY2018 to FY2027 to date; 0 classified OAI
How to read this
A hatched bar is a year that is not over, so its count covers only part of the year.
21 CFR 820.90(a). Nonconforming product control Products that do not conform to specifications are not adequately controlled.
21 CFR 820.80(b). Lack of or inadequate receiving acceptance procedures Procedures for acceptance of incoming product have not been established.
21 CFR 820.50. Purchasing controls, Lack of or inadequate procedures Procedures to ensure that all purchased or otherwise received product and services conform to specified requirements have not been established.
21 CFR 820.22. Quality audits - auditor independence Individuals who conduct quality audits have direct responsibility for the matters being audited.
21 CFR 820.25(b). Training - Lack of or inadequate procedures Procedures for training and identifying training needs have not been established.
21 CFR 803.17. Lack of Written MDR Procedures Written MDR procedures have not been implemented.
21 CFR 820.30(i). Design changes - Lack of or Inadequate Procedures Procedures for design change have not been adequately established.
21 CFR 820.72(b). Calibration procedures - content Calibration procedures do not include provisions for remedial action.
21 CFR 820.72(b). Remedial action When test/measurement equipment was found to not meet accuracy and precision limits, no action was taken to bring the equipment into calibration and evaluate whether there was any adverse effect on the device's quality.
21 CFR 820.90(a). Nonconforming product, Lack of or inadequate procedures Procedures have not been adequately established to control product that does not conform to specified requirements.
21 CFR 820.250(b). Sampling plans Sampling plans are not based on valid statistical rationale.
21 CFR 820.50(a)(1). Documented evaluation The evaluation of potential suppliers was not documented.
21 CFR 820.50(b). Supplier notification of changes There is no agreement with suppliers to notify you of changes in the product or service.
21 CFR 820.72(a). Equipment control activity documentation Equipment calibrations have not been documented.
21 CFR 820.20(c). Management review - Lack of or inadequate procedures Procedures for management review are not established, defined, documented, and implemented.
21 CFR 820.20(c). Management review - defined interval, sufficient frequency Management reviews were not conducted at defined intervals and with sufficient frequency.
21 CFR 820.22. Quality Audits - defined intervals Quality audits did not verify that the quality system is effective in fulfilling your quality system objectives.
21 CFR 820.50(a)(1). Documented evaluation The evaluation of potential suppliers was not documented.
21 CFR 820.30(a). Design control - no procedures Procedures to control the design process of the device were not defined, documented, and implemented.
Voluntary Action Indicated (VAI)
Warning Letters
Letters naming this establishment; each opens the letter
An FEI (FDA Establishment Identifier) names one physical site. Inspections, outcomes and citations come from FDA's Data Dashboard; FDA posts citations only for some inspections. Recalls come from FDA's enforcement reports (iRES), one row per recall even when it covers many lots. A contract site can make products for many companies, so the company shown is the one FDA lists as the site's firm.FDA Data Dashboard, warning letters and enforcement reports